News
Prioritise affordable treatment of sickle cell treatment —Health Expert
Health experts have urged Ghana to prioritise affordable and accessible treatment for sickle cell disease (SCD) as advanced, but costly curative therapies remain out of reach.
SCD, an inherited blood disorder, affects about three in every 100 newborns in Ghana.
Globally, around 1,000 babies are born with the condition daily, with three-quarters in sub-Saharan Africa.
The disease causes severe complications including chronic pain, anaemia, infections, strokes and organ damage, often leading to shortened life expectancy.
In recent years, gene therapy has been developed as a potential cure.
However, its cost—running into millions of dollars per patient—makes it financially and technically inaccessible in Ghana.
According to Dr Lawrence Osei-Tutu, a Sickle Cell and Childhood Cancer Expert at the Komfo Anokye Teaching Hospital, “the country must instead focus on practical, lower-cost interventions such as hydroxyurea”, a decades-old cancer drug proven to reduce painful episodes, hospitalisation and life- threatening complications in SCD patients”.
Taken orally, the medicine improves red blood cell function and is considered safe and effective.
“Hydroxyurea therapy is as good as the cure and a low-hanging fruit to pluck, we must bring a cure to our sickle cell warriors, but do so sustainably.” he urged.
In a chat with The Spectator here, he said to create awareness on the disease, the expert noted that despite its benefits, “hydroxyurea is not widely accessible in Ghana.”
Stressing that, “many patients either cannot afford it or struggle with irregular supply through the health system.”
Moreover, he argued that scaling up access would provide immediate relief while the country builds the infrastructure, trains specialists and secures funding needed to support curative therapies in the future.
With an estimated 15,000 babies born with sickle cell disease annually in Ghana, Dr Osei Tutu cautioned that “failure to improve access to effective treatment will leave many patients vulnerable to preventable complications and early death.”
From Kingsley E. Hope, Kumasi
Join our WhatsApp Channel now!
https://whatsapp.com/channel/0029VbBElzjInlqHhl1aTU27
